Employees Retirement System of Texas’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Employees Retirement System of Texas’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,542	Closed	-$3.01M	–	371
2023 Q1	$3.01M	Sell	27,542 -52,180	-65%	-$5.77M	0.04%	213
2022 Q4	$9.07M	Sell	79,722 -34,521	-30%	-$2.87M	0.13%	169
2022 Q3	$7.07M	Buy	+114,243	New	+$7.98M	0.11%	201

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Employees Retirement System of Texas's HZNP Position: Q2 2023 in Review

Employees Retirement System of Texas sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 27,542 shares — an estimated $3.01M sold.

Employees Retirement System of Texas first reported a position in HZNP in Q3 2022 and held it in 3 quarters. The position peaked at $9.07M in Q4 2022. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Employees Retirement System of Texas reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Employees Retirement System of Texas sold 27,542 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $3.01M.
Employees Retirement System of Texas first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022 and held it in 3 quarters.
Employees Retirement System of Texas's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $9.07M in Q4 2022.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Employees Retirement System of Texas's 13F filing for Q2 2023, filed 11 Aug 2023.